Therapeutic Asset Ratings
9,928 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti-interleukin-7 Receptor ? Monoclonal antibody
Acute Lymphoblastic Leukemia
Allterum Therapeutics, Inc
P1
CC
(43)
Anti-Lilra6 Car-T Cells
Acute Myeloid Leukemia
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelodysplastic Syndrome With Excess Blasts-1
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Myelodysplastic Syndrome With Excess Blasts-2
M.D. Anderson Cancer Center
P1
CC
(43)
Anti-Pr1/Hla-A2 Monoclonal Antibody Hu8F4
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
anv419
Hematologic Disorder
Anaveon AG
P1
CC
(43)
Anvumetostat
Digestive System Cancer
Amgen
P1
CC
(43)
Anvumetostat
Neoplasm Of Thorax
Amgen
P1
CC
(43)
ao-252
Metastatic Malignant Neoplasm In The Brain
A2A Pharmaceuticals Inc.
P1
CC
(43)
APG 2449
Malignant Pleural Mesothelioma
Ascentage Pharma Group Inc.
P1
CC
(43)
Apg-5918
Castration-Resistant Prostate Carcinoma
Ascentage Pharma Group Inc.
P1
CC
(43)
Apg-5918
Epithelioid Sarcoma
Ascentage Pharma Group Inc.
P1
CC
(43)
Apl-4098
Acute Myeloid Leukemia
Apollo Therapeutics Ltd
P1
CC
(43)
Apl-4098
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Apollo Therapeutics Ltd
P1
CC
(43)
Apl-4098
Myelodysplastic Syndrome With Excess Blasts
Apollo Therapeutics Ltd
P1
CC
(43)
Apnmab005
Tauopathy
APRINOIA Therapeutics, LLC
P1
CC
(43)
aps03118
RET Fusion Positive Cancer
Applied Pharmaceutical Science, Inc.
P1
CC
(43)
AQUOCOBALAMIN
Breast Adenocarcinoma
General Oncology, Inc.
P1
CC
(43)
AQUOCOBALAMIN
Breast Cancer
General Oncology, Inc.
P1
CC
(43)
AQUOCOBALAMIN
PALB2-Related Cancer Predisposition
General Oncology, Inc.
P1
CC
(43)
AQUOCOBALAMIN
Pancreatic Acinar Cell Carcinoma
General Oncology, Inc.
P1
CC
(43)
Showing 951 to 975 of 9,928 assets
Previous
Page 39 of 398
Next